Repository navigation
Expand file tree
/
Copy pathfeed.xml
More file actions
95 lines (94 loc) · 6.82 KB
/
Copy pathfeed.xml
File metadata and controls
95 lines (94 loc) · 6.82 KB
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Fritsche Lab updates</title>
<link href="https://fritschelab.org/feed.xml" rel="self" type="application/atom+xml"/>
<link href="https://fritschelab.org/"/>
<id>https://fritschelab.org/</id>
<updated>2026-06-08T00:00:00-04:00</updated>
<author><name>Fritsche Lab</name></author>
<entry>
<title>Studying depressive symptoms after surgery</title>
<link href="https://fritschelab.org/news/postoperative-depression-project-2026/"/>
<id>https://fritschelab.org/news/postoperative-depression-project-2026/</id>
<updated>2026-06-08T00:00:00-04:00</updated>
<summary type="html">A two-year project aims to identify patients who may need additional support for depressive symptoms after surgery.</summary>
</entry><entry>
<title>U-M researchers aim to shorten the path to effective mental health care</title>
<link href="https://fritschelab.org/news/compass-mental-health-care-2026/"/>
<id>https://fritschelab.org/news/compass-mental-health-care-2026/</id>
<updated>2026-06-08T00:00:00-04:00</updated>
<summary type="html">COMPASS participants contribute repeated reports, genetic samples, and health record data to study why mental health treatment responses differ.</summary>
</entry><entry>
<title>Comparing cancer immunotherapy outcomes in Black and white patients</title>
<link href="https://fritschelab.org/news/cancer-immunotherapy-outcomes-2024/"/>
<id>https://fritschelab.org/news/cancer-immunotherapy-outcomes-2024/</id>
<updated>2024-12-04T00:00:00-05:00</updated>
<summary type="html">A study using Veterans Health Administration records compared survival and immune-related adverse events in Black and white patients receiving cancer immunotherapy.</summary>
</entry><entry>
<title>MGI 2024: Lars Fritsche</title>
<link href="https://fritschelab.org/news/mgi-2024-lars-fritsche-video/"/>
<id>https://fritschelab.org/news/mgi-2024-lars-fritsche-video/</id>
<updated>2024-10-15T00:00:00-04:00</updated>
<summary type="html">A U-M symposium talk by Lars Fritsche examines a decade of genetics research linked to electronic health records, with examples from PheWeb and PRSweb.</summary>
</entry><entry>
<title>U-M announces NIMH-backed COMPASS precision mental health grant</title>
<link href="https://fritschelab.org/news/compass-grant-2024/"/>
<id>https://fritschelab.org/news/compass-grant-2024/</id>
<updated>2024-07-09T00:00:00-04:00</updated>
<summary type="html">A $17.9 million NIMH award supports COMPASS, a collaboration studying differences in mental health treatment response.</summary>
</entry><entry>
<title>Comparing methods for evaluating COVID-19 booster effectiveness</title>
<link href="https://fritschelab.org/news/covid-vaccine-effectiveness-2024/"/>
<id>https://fritschelab.org/news/covid-vaccine-effectiveness-2024/</id>
<updated>2024-02-01T00:00:00-05:00</updated>
<summary type="html">A comparison of observational methods examined how study design and analysis choices affect estimates of COVID-19 booster effectiveness.</summary>
</entry><entry>
<title>Estimating the global prevalence of long COVID</title>
<link href="https://fritschelab.org/news/long-covid-prevalence-2022/"/>
<id>https://fritschelab.org/news/long-covid-prevalence-2022/</id>
<updated>2022-04-20T00:00:00-04:00</updated>
<summary type="html">A systematic review and meta-analysis combined 50 studies to compare long COVID prevalence across regions, follow-up periods, and hospitalization status.</summary>
</entry><entry>
<title>Evaluating cancer polygenic risk scores across ancestry groups</title>
<link href="https://fritschelab.org/news/cross-ancestry-cancer-prs-2021/"/>
<id>https://fritschelab.org/news/cross-ancestry-cancer-prs-2021/</id>
<updated>2021-09-16T00:00:00-04:00</updated>
<summary type="html">Cancer polygenic risk scores were evaluated across ancestry groups in UK Biobank, highlighting the need for more diverse genetic studies.</summary>
</entry><entry>
<title>Democratizing genetic data for cancer research</title>
<link href="https://fritschelab.org/news/cancer-prsweb-genetic-data-2020/"/>
<id>https://fritschelab.org/news/cancer-prsweb-genetic-data-2020/</id>
<updated>2020-11-20T00:00:00-05:00</updated>
<summary type="html">Cancer PRSweb provides archived comparisons of cancer polygenic risk scores in the Michigan Genomics Initiative and UK Biobank.</summary>
</entry><entry>
<title>Genetic risk for abdominal aortic aneurysm</title>
<link href="https://fritschelab.org/news/abdominal-aortic-aneurysm-genetics-2020/"/>
<id>https://fritschelab.org/news/abdominal-aortic-aneurysm-genetics-2020/</id>
<updated>2020-09-28T00:00:00-04:00</updated>
<summary type="html">A genetic study in the Million Veteran Program identified regions associated with abdominal aortic aneurysm and evaluated a polygenic risk score.</summary>
</entry><entry>
<title>Max Salvatore on COVID-19 modeling in India</title>
<link href="https://fritschelab.org/news/covid-modeling-max-salvatore-2020/"/>
<id>https://fritschelab.org/news/covid-modeling-max-salvatore-2020/</id>
<updated>2020-09-22T00:00:00-04:00</updated>
<summary type="html">Max Salvatore reflects on his cancer research experience and subsequent work modeling COVID-19 in India.</summary>
</entry><entry>
<title>Eye expert leads research to better predict blindness in patients</title>
<link href="https://fritschelab.org/news/amd-blindness-prediction-funding-2018/"/>
<id>https://fritschelab.org/news/amd-blindness-prediction-funding-2018/</id>
<updated>2018-07-12T00:00:00-04:00</updated>
<summary type="html">An international collaboration combines clinical measures, retinal imaging, genetics, and machine learning to study progression of age-related macular degeneration.</summary>
</entry><entry>
<title>Evaluating cancer polygenic risk scores in the Michigan Genomics Initiative</title>
<link href="https://fritschelab.org/news/cancer-polygenic-scores-2018/"/>
<id>https://fritschelab.org/news/cancer-polygenic-scores-2018/</id>
<updated>2018-05-18T00:00:00-04:00</updated>
<summary type="html">Cancer polygenic risk scores were associated with diagnoses of cancers and related conditions in the Michigan Genomics Initiative.</summary>
</entry><entry>
<title>Common and rare genetic variants in age-related macular degeneration</title>
<link href="https://fritschelab.org/news/amd-genetic-clues-2015/"/>
<id>https://fritschelab.org/news/amd-genetic-clues-2015/</id>
<updated>2015-12-21T00:00:00-05:00</updated>
<summary type="html">An international study of about 43,000 people identified common and rare genetic variants associated with age-related macular degeneration.</summary>
</entry>
</feed>